PRTODAY / NewswireToday Free press release distribution service network

More news: Software
Written by / Agency / Source: Kenexa | IBM

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bausch + Lomb and IBM Collaborate on Innovative App for iPhone and iPad for Cataract Surgeons on IBM Cloud - First-of-its-Kind App to Provide Clinical Insights to help Surgeons Customize Intraocular Lens Selection - Bausch.com / IBM.com
Bausch + Lomb and IBM Collaborate on Innovative App for iPhone and iPad for Cataract Surgeons on IBM Cloud

 

NewswireToday - /newswire/ - Bridgewater, NJ, United States, 2016/05/05 - First-of-its-Kind App to Provide Clinical Insights to help Surgeons Customize Intraocular Lens Selection - Bausch.com / IBM.com. NASDAQ: KNXA

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bausch + Lomb, a leading global eye health company, and IBM today announced a collaboration to develop the first app of its kind for iPhone and iPad for surgeons who perform cataract surgery. The innovative app will help surgeons streamline their workflow by delivering patient information and clinical insights as well as intraocular lens (IOL) options on a single, digital platform at the point of care.

Cataract extraction is the most common surgical procedure among Medicare beneficiaries and cataract rates are on the rise1. Cataracts affect more than 22 million Americans and that number is expected to rise to 30 million by 20202. Cataracts a clouding of the eye’s lens that can lead to blindness if untreated affect approximately 70 percent of people by age 753. In cataract surgery, the cloudy lens is removed and replaced with an artificial lens an IOL.

Today, many cataract surgeons consult patient data in the operating room (OR) via print-outs or notes created during pre-op patient office visits, which can often be bothersome and inefficient. The new app from Bausch + Lomb will be designed to provide surgeons with access to information that patients have agreed to share, enabling doctors to plan their surgical interventions -- including IOL selection -- and have the option to view the information on digital devices or display screens on walls in the operating room during surgery.

The app will be designed to electronically manage patient data across iPhone and iPad while hosting health-related data on IBM Cloud Platform, Bluemix -- a security rich, cloud-based environment -- and relaying customized IOL options to surgeons that they will use to help enhance surgical planning and provide better patient care. The MobileFirst for iOS team, which is part of IBM Global Business Services, will design and develop this custom app for Bausch + Lomb to help drive innovation in healthcare. Bausch + Lomb’s vision is to optimize the app to collect data over time, resulting in a cognitive app that applies machine-based learning and predictive analytics to deliver real-time insights to surgeons.

By compiling each cataract patient’s information in the app -- including IOL calculations, corneal topography and other biometry results as well as lifestyle preferences -- surgeons and their staff may generate a comprehensive, integrated profile to help them facilitate IOL selection and procedure planning. Historical surgical data and other patient insights can also be housed within the app to potentially support positive clinical outcomes for future cataract.

“Bausch + Lomb is excited to collaborate with IBM to develop this innovative platform for ophthalmology,” said Andy Chang, senior vice president and general manager, U.S. Surgical, Bausch + Lomb. “By combining IBM’s advanced data management capabilities with Apple’s innovative app ecosystem and our clinical expertise, we are working to provide surgeons with a convenient, personalized tool that helps them better manage and access patient profiles digitally, and provide personalized IOL options. This unique relationship demonstrates Bausch + Lomb’s unwavering commitment to being a driving force in the ophthalmology industry by developing novel solutions that address the unmet needs of our customers and their patients.”

“IBM works closely with companies to deliver a mobile experience that transforms how professionals work across industries and we look forward to bringing the benefits of mobile technology to some of the world’s busiest surgeons -- cataract surgeons,” said Mahmoud Nagshineh, general manager, Apple partnership, IBM. “Bausch + Lomb has identified a significant need in the ophthalmic community and the new app we will create will equip ophthalmologists with the data they need at their fingertips to help them make better, more informed decisions for their patients.”

“This new mobile solution has real potential to fundamentally change how our practice manages patient information throughout the cataract procedure, from planning through post-operative follow-up,” said Anil Shivaram, M.D., from Claremont Eye Associates in Claremont, CA. “Additionally, having the ability to access the variety of each patient’s surgical information on an iPhone or iPad will allow surgeons to streamline their time management and decision-making process. Allowing this mobile platform to organize and essentialize the numerous data sets that cataract surgeons must tackle with each case will also allow for refinement over time for each individual surgeon. By capturing, displaying, and analyzing the data over time in an iterative process, this app is expected to help surgeons provide better care and potentially help provide improved surgical outcomes, while at the same time increasing their efficiency.”

Pilot study testing for the new application is expected to begin in late 2016.

About Cataract Surgery
Cataract surgery is the most common surgical procedure among Medicare beneficiaries, and cataract rates are on the rise. Cataracts affect more than 22 million Americans and that number is expected to grow to 30 million by 2020. Cataracts a clouding of the eye’s lens that can lead to blindness if untreated affect approximately 70 percent of people by age 75. In cataract surgery, the cloudy lens is removed and replaced with an artificial lens an intraocular lens (IOL). Similar to contact lenses, there are a wide variety of IOLs for surgeons to select based on a number of factors for each patient including lifestyle preferences and other specific visual needs.

About Bausch + Lomb
Bausch + Lomb (bausch.com), a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. We develop, manufacture and market one of the most comprehensive product portfolios in our industry, which is available in more than 100 countries.

All statements regarding IBM’s future direction and intent are subject to change or withdrawal without notice, and represents goals and objections only.

1. Ophthalmic Epidemiology (2012)
2. Journal of Cataract and Refractive Surgery
3. American Academy of Ophthalmology

Contacts:
Teresa Panas - BioComm Network, on behalf of Bausch + Lomb
P: 973-809-8590 - E: tpanas[.]biocommnetwork.com.

Kristy Marks - Manager, Product PR, Bausch + Lomb
P: 908-927-0683 - E: kristy.marks[.]bausch.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kenexa | IBM

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


Bausch + Lomb and IBM Collaborate on Innovative App for iPhone and iPad for Cataract Surgeons on IBM Cloud

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Marisa Conway - IBM.com 
212-671-9408 conwaym[.]us.ibm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kenexa | IBM securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kenexa | IBM / Company Profile


Read Software Most Recent Related Newswires:

Kentico Releases its Most Enterprise-Ready Solution Yet
OneLogin Delivers First-Ever Multi-Environment AWS User Resource Provisioning
Mahindra and IBM to Develop Blockchain Solution for Supply Chain Finance
Toyota Motor Corporation Approves Mentor Graphics Volcano™ VSTAR AUTOSAR Stack for Deployment in Toyota Vehicles
Wiley Launches New Spectra Lab Applications to Help Scientists Manage Analytical Data
Earthlite Drastically Simplifies and Expedites Accounts Receivable Analysis with Datawatch Monarch
PTC Achieves AWS IoT Competency Status
Umbra, VM Backup Appliance Based on NAKIVO Backup & Replication, Generates Business for Integrative
SpringCM Chooses Xactly to Increase Data Accuracy and Enhance Sales Compensation Strategy
American Airlines Selects IBM as its Cloud Provide
Solenis Chooses OpenText to Digitize and Manage its Global B2B Supply Chain
Canadian Long Term Care Provider Selects Yardi Senior Living Software
TIBCO Jaspersoft for Docker Offering Enables Agile Development and DevOps Excellence
Pegasystems Introduces New Connectors to Enable Rapid Exchange of Electronic Health Records for Better Patient Care
Mentor Graphics FloEFD Computational Fluid Dynamics (CFD) Technology Attributed to NASCAR Championship Win

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)